title: Revising common beliefs in the management of stable CAD.
abstract: New findings published in 2012 have challenged common beliefs about stable coronary artery disease. Studies have shown that β-blockers and n-3-polyunsaturated fatty acids have no impact on prognosis, that percutaneous coronary intervention is not always the best option, and that women do not have worse cardiovascular outcomes than men.
authors.affiliation: Department of Cardiology, University Hospital of Ferrara, Via Aldo Moro 8, 44124 Cona (Ferrara), Italy. fri@unife.it
authors.forename: Roberto
authors.initials: R
authors.lastname: Ferrari
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000628:therapy*; D019317:Evidence-Based Medicine; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D005260:Female; D054624:Health Status Disparities; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects; D012307:Risk Factors; D012720:Severity of Illness Index; D012737:Sex Factors; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D002317:Cardiovascular Agents; D015525:Fatty Acids, Omega-3